Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_assertion description "[CtBP2-specific inhibitors, such as MTOB, may be effective adjunct therapies in the management of patients with CtBP2-positive ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_assertion evidence source_evidence_literature NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_assertion SIO_000772 23730208 NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_assertion wasDerivedFrom befree-20150227 NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_assertion wasGeneratedBy ECO_0000203 NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP334409.RAid58S6PD0pwE0kSmqlF4O98fPEFqLvjfq_BLnqJN_oM130_provenance.